Baker Bros. Advisors Lp

13F Holdings History for Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

Symbol: EWTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 7.31M shares
Security Ownership: 6.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Baker Bros. Advisors LP ownership in Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX)

2025-08-14 - Baker Bros. Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.31M shares of Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX). This represents 6.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Baker Bros. Advisors LP	6.9%		$107M	7.31M			$14.65	13G/A	6/30/2025	14 Aug 2025 16:28:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.86%		$119M	7.31M			$16.22	Q3 2025
6/30/2025	0.93%	+0.15%	$95.8M	7.31M	+1,150,000	+18.7%	$13.11	Q2 2025
3/31/2025	1.5%		$135M	6.16M			$22.00	Q1 2025
12/31/2024	1.76%	+0.09%	$164M	6.16M	+315,881	+5.41%	$26.70	Q4 2024
9/30/2024	1.62%		$156M	5.84M			$26.69	Q3 2024
6/30/2024	1.34%		$105M	5.84M			$18.01	Q2 2024
3/31/2024	1.34%	+0.57%	$107M	5.84M	+2,727,273	+87.6%	$18.24	Q1 2024
12/31/2023	0.39%	+0.13%	$34.1M	3.11M	+2,063,087	+197%	$10.94	Q4 2023
9/30/2023	0.03%	+0.02%	$6.01M	1.05M	+549,699	+110%	$5.73	Q3 2023
6/30/2023	0.02%		$3.88M	500K			$7.75	Q2 2023
3/31/2023	0.02%		$3.34M	500K			$6.67	Q1 2023
12/31/2022	0.03%		$4.47M	500K			$8.94	Q4 2022
9/30/2022	0.03%		$4.92M	500K			$9.84	Q3 2022
6/30/2022	0.02%		$3.98M	500K			$7.96	Q2 2022
3/31/2022	0.03%		$4.85M	500K			$9.70	Q1 2022
12/31/2021	0.04%		$7.64M	500K			$15.28	Q4 2021
9/30/2021	0.04%		$8.3M	500K			$16.60	Q3 2021
6/30/2021	0.05%		$10.7M	500K			$21.33	Q2 2021
3/31/2021	0.07%	+0.06%	$16.3M	500K	+500,000	NEW	$32.50	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.